Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00134004 · FLOW

Participant flow

Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer · Source last updated 2015-10-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Non-myeloablative haploidentical bone marrow transplant with a fludarabine, cyclophosphamide (Cy), TBI (total body irradiation) preparative regimen and post-transplant Cy, mycophenolate mofetil (MMF), and tacrolimus as GVHD prophylaxis.
    id
    FG000
    title
    Mini-haplo BMT
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        210
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        210
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Non-myeloablative haploidentical bone marrow transplant with a fludarabine, cyclophosphamide (Cy), TBI (total body irradiation) preparative regimen and post-transplant Cy, mycophenolate mofetil (MMF), and tacrolimus as GVHD prophylaxis.
    id
    FG000
    title
    Mini-haplo BMT
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        210
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        210
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice